Filed: 11/13/2023ACC: 0001766721-23-000004
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $242.68M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
17
Positions
$242.68M
Total AUM (reported)
22.46M
Total Shares
Allocation by class
COM$213.03M87.8%
SPONSORED ADS$25.32M10.4%
COM CL A$3.40M1.4%
COM NEW$828.7K0.3%
CL A COM$101.2K0.0%
Portfolio Concentration
Top 3$193.08M79.6%
4–10$41.03M16.9%
11–25$8.57M3.5%
Top 3 weight
79.6%
Top 10 weight
96.5%
Voting Authority Distribution
Total shares with voting rights: 22.46M
Sole
Full voting authority
22.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole17
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings17
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$160.02M
65.94%
Sole
6.07M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.12M
TypeSH
Market value$18.18M
7.49%
Sole
1.12M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$14.88M
6.13%
Sole
1.02M
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares798.76K
TypeSH
Market value$10.99M
4.53%
Sole
798.76K
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares964.50K
TypeSH
Market value$7.14M
2.94%
Sole
964.50K
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$7.05M
2.91%
Sole
1.47M
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc (RPHM)
SOLEShares886.08K
TypeSH
Market value$6.74M
2.78%
Sole
886.08K
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$3.40M
1.40%
Sole
2.54M
Shared
0.00
None
0.00
Aclaris Theraputics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$2.98M
1.23%
Sole
434.45K
Shared
0.00
None
0.00
Spruce Biosciences, Inc. (SPRB)
SOLEShares1.21M
TypeSH
Market value$2.72M
1.12%
Sole
1.21M
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$2.48M
1.02%
Sole
1.04M
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$1.88M
0.77%
Sole
2.83M
Shared
0.00
None
0.00
Avrobio, Inc. (AVRO)
SOLEShares1.01M
TypeSH
Market value$1.56M
0.64%
Sole
1.01M
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares314.29K
TypeSH
Market value$1.43M
0.59%
Sole
314.29K
Shared
0.00
None
0.00
Aeglea Biotherapeutics Inc (AGLE)
SOLEShares67.64K
TypeSH
Market value$828.7K
0.34%
Sole
67.64K
Shared
0.00
None
0.00
Viracta Therapeutics Inc (VIRX)
SOLEShares288.57K
TypeSH
Market value$300.1K
0.12%
Sole
288.57K
Shared
0.00
None
0.00
Atreca Inc. (BCEL)
SOLEShares387.65K
TypeSH
Market value$101.2K
0.04%
Sole
387.65K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $160.02M 65.94% | 6.07M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.12M | SH | $18.18M 7.49% | 1.12M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $14.88M 6.13% | 1.02M | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 798.76K | SH | $10.99M 4.53% | 798.76K | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 964.50K | SH | $7.14M 2.94% | 964.50K | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $7.05M 2.91% | 1.47M | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc (RPHM)SOLE | COM | 886.08K | SH | $6.74M 2.78% | 886.08K | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $3.40M 1.40% | 2.54M | 0.00 | 0.00 |
Aclaris Theraputics Inc (ACRS)SOLE | COM | 434.45K | SH | $2.98M 1.23% | 434.45K | 0.00 | 0.00 |
Spruce Biosciences, Inc. (SPRB)SOLE | COM | 1.21M | SH | $2.72M 1.12% | 1.21M | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $2.48M 1.02% | 1.04M | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $1.88M 0.77% | 2.83M | 0.00 | 0.00 |
Avrobio, Inc. (AVRO)SOLE | COM | 1.01M | SH | $1.56M 0.64% | 1.01M | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM | 314.29K | SH | $1.43M 0.59% | 314.29K | 0.00 | 0.00 |
Aeglea Biotherapeutics Inc (AGLE)SOLE | COM NEW | 67.64K | SH | $828.7K 0.34% | 67.64K | 0.00 | 0.00 |
Viracta Therapeutics Inc (VIRX)SOLE | COM | 288.57K | SH | $300.1K 0.12% | 288.57K | 0.00 | 0.00 |
Atreca Inc. (BCEL)SOLE | CL A COM | 387.65K | SH | $101.2K 0.04% | 387.65K | 0.00 | 0.00 |